세계의 대규모 및 소규모 바이오프로세싱 시장 규모, 점유율, 산업 동향 분석 리포트 : 규모별, 사용 유형별, 모드별, 용도별, 워크플로우별, 제품별, 지역별 전망과 예측(2023-2030년)

The Global Large And Small-scale Bioprocessing Market size is expected to reach $159.6 billion by 2030, rising at a market growth of 14.2% CAGR during the forecast period.

The biopharmaceutical industry's expansion has spurred continuous advancements in bioprocessing technologies. Therefore, Biopharmaceuticals segment would generate $35,141.7 million revenue in the market in 2022. As a result, the constant innovation within the biopharmaceutical industry has a positive feedback loop, driving the evolution of bioprocessing technologies and equipment. As biopharmaceutical companies strive to optimize their manufacturing processes, they invest in cutting-edge equipment, automation, and process control systems.

The major strategies followed by the market participants are Geographical Expansion as the key developmental strategy to keep pace with the changing demands of end users. For instance, In September, 2022, Eppendorf Group expanded its Julich bioprocess site by constructing a new multifunctional building. Moreover, In April, 2022, Thermo Fisher Scientific set up a new single-use technology manufacturing site in Ogden, Utah, enhancing capacity for high-quality materials crucial in developing vaccines and therapies. This expansion strengthens the company's Utah presence and facilitates close collaboration with the Logan site, tapping into a skilled workforce for manufacturing intricate, customized solutions.

Based on the Analysis presented in the KBV Cardinal matrix; F. Hoffmann-La Roche Ltd. is the major forerunner in the Market. Companies such as Merck KGaA, Thermo Fisher Scientific, Inc., and Boehringer Ingelheim International GmbH are some of the key innovators in the Market. In July, 2023, Sartorius AG expanded its site in Yauco, Puerto Rico, by incorporating a new cell culture media manufacturing facility. This addition solidified their extensive portfolio, particularly catering to customers in the Americas.

COVID-19 Impact Analysis

The pandemic led to an urgent need for COVID-19 vaccines, which required rapidly scaling up large-scale bioprocessing facilities. This resulted in increased demand for bioprocessing equipment, single-use technologies, and expertise in large-scale vaccine production. The pandemic prompted increased funding for research, including small-scale bioprocessing activities related to developing diagnostics, therapeutics, and vaccines. Academic and research labs received substantial funding for COVID-19-related projects. Many small-scale bioprocessing labs shifted to remote work and virtual collaboration to comply with social distancing measures. This accelerated the adoption of digital tools and software for data analysis, experiment planning, and communication. Therefore, COVID-19 impact had an overall positive effect on the market.

Market Growth Factors

Rising demand for biosimilars, generic biologics, and personalized medicine

The demand for biosimilars and generic biologics, driven by the expiration of patents on biologic drugs, has significantly impacted the large-scale bioprocessing. Biosimilars and generic biologics aim to provide more affordable alternatives to biologic drugs, making them more accessible to patients. To meet this growing demand, large-scale bioprocessing facilities are required to produce these biologics efficiently and cost-effectively. As a result, the large-scale bioprocessing businesses have seen a boost in activity, with increased investment in production facilities and equipment. Therefore, the increasing demand for these pharmaceuticals is propelling the growth of the market.

Advancements in bioprocessing technologies

Continuous advancements in bioprocessing equipment, automation, and analytics improve the efficiency and scalability of large-scale production. Single-use bioprocessing equipment and systems have become increasingly popular in large-scale bioprocessing. These systems eliminate the need for cleaning and sterilization, reducing downtime and the risk of contamination. Continuous bioprocessing is gaining traction as an alternative to traditional batch processing. Automated high-throughput screening technologies help rapidly screen cell lines, culture conditions, and process parameters, accelerating process development for large-scale production. Advancements in bioprocessing technologies have significantly impacted the market.

Market Restraining Factors

Stringent regulatory compliance

Small-scale bioprocessing labs, especially in academic or startup settings, have limited resources and expertise to navigate complex regulatory requirements. Establishing and maintaining quality systems, including standard operating procedures (SOPs) and documentation, can be challenging for smaller organizations with fewer personnel. Transitioning from small-scale to larger-scale production while maintaining compliance can be difficult, especially when processes and equipment need to be adapted. Thus, regulatory compliance is a significant challenge in large and small-scale bioprocessing market.

Scale Outlook

By scale, the market is categorized into industrial scale and small scale. In 2022, the industrial scale segment held the highest revenue share in the market. Large-scale bioprocessing at volumes exceeding 50,000 litres is often associated with producing monoclonal antibodies, vaccines, and other biopharmaceuticals. These products require large quantities to meet global demand. Due to their durability and capacity to endure high pressures and volumes, stainless steel bioreactors are frequently used in large-scale bioprocessing facilities.

Use Type Outlook

Based on use type, the market is fragmented into multi use and single use. The single use segment covered a considerable revenue share in the market in 2022. Single use systems are highly adaptable and readily scaled to accommodate fluctuating production requirements. This scalability is valuable for large and small-scale bioprocessing operations, allowing them to adapt to evolving market demands. Single-use systems can reduce downtime associated with cleaning, sterilization, and changeover between batches. This results in faster turnaround times, making it easier to quickly meet production schedules and respond to market demands.

Mode Outlook

On the basis of mode, the market is bifurcated into in-house and outsourced. The outsourced segment acquired a substantial revenue share in the large and small-scale bioprocessing market in 2022. Large pharmaceutical and biotechnology companies outsource bioprocessing to contract manufacturing organizations (CMOs) to produce biopharmaceuticals. CMOs have the infrastructure and expertise to scale up production quickly to meet high demand. CMOs often specialize in certain types of bioprocessing, such as monoclonal antibody production or vaccine manufacturing. Large-scale companies can benefit from these service providers' specialized knowledge and experience. Small biotech startups and research institutions lack the specialized equipment and facilities for certain bioprocessing activities. Outsourcing provides access to advanced equipment and infrastructure.

Application Outlook

By application, the market is segmented into biopharmaceuticals, speciality industrial chemicals, and environmental aids. In 2022, the biopharmaceuticals segment registered the maximum revenue share in the market. The primary application of bioprocessing is the commercial production of biopharmaceuticals for the market. This includes manufacturing large quantities of monoclonal antibodies, vaccines, recombinant proteins, and other biologics. Monoclonal antibodies are widely used to treat cancer, autoimmune diseases, and infectious diseases. Many biopharmaceutical companies outsource the large-scale production of their products to contract manufacturing organizations (CMOs).

Workflow Outlook

Based on workflow, the market is classified into downstream processing, fermentation, and upstream processing. The fermentation segment acquired a substantial revenue share in the market in 2022. Large-scale fermentation allows the production of substantial quantities of products. Large-scale fermentation processes often benefit from economies of scale, resulting in lower production costs per product unit. This is critical for cost-effective manufacturing of biopharmaceuticals and other high-value products. Large-scale fermenters have advanced monitoring and control systems to ensure consistent product quality.

Product Outlook

On the basis of product, the market is divided into bioreactors/fermenters, cell culture products, filtration assemblies, bioreactors accessories, bags & containers, and others. In 2022, the bioreactors/fermenters segment dominated the market with maximum revenue share. Large-scale biopharmaceutical manufacturing facilities typically employ stainless steel bioreactors. These bioreactors are designed for high-volume production and are known for their durability, sterility, and ability to withstand high pressure and temperature conditions. There has been a growing trend in large-scale bioprocessing towards adopting single-use bioreactors. These systems offer flexibility, reduce the risk of contamination, and minimize the need for time-consuming cleaning and sterilization processes.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America is home to numerous large pharmaceutical and biotechnology companies that use large-scale bioprocessing to produce biopharmaceuticals, including monoclonal antibodies, vaccines, gene therapies, and more. North America boasts state-of-the-art biomanufacturing facilities with large-scale bioreactors, downstream processing units, and quality control systems. North America, particularly the United States, has a thriving ecosystem of biotech startups that engage in small-scale bioprocessing for research, development, and early-stage product testing.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., GE healthcare, Corning Incorporated, Sartorius AG, Lonza Group AG (Capsugel), Meissner Filtration Products, Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd. and Eppendorf SE.

Recent Strategies developed in Large and Small-scale Bioprocessing Market

Partnerships, Collaborations, and Agreements:

Oct-2023: Boehringer Ingelheim International GmbH collaborated with ZEISS Medical Technology, a multinational medical technology company and subsidiary of Carl Zeiss AG, to develop predictive analytics for the early detection of eye diseases and personalized treatments to prevent vision loss. The partnership, which brought together their expertise in ophthalmological technology, data analytics, algorithms, and first-in-class treatments, aimed to detect and treat retinal diseases early, preventing irreversible vision loss.

May-2023: Merck KGaA had signed a non-binding MoU with Ministry of Trade, Industry and Energy (MOTIE) and Daejeon City for an Asia-Pacific BioProcessing Center. The facility, aimed at aiding the region's healthcare ecosystem, would support commercial manufacturing for biotech and pharmaceutical clients in Asia-Pacific, serving as a vital hub for industry development in South Korea.

Apr-2023: Sartorius AG came into partnership with va-Q-tec, an innovator in thermal insulation solutions, to enhance logistics for shipping bulk drug substances (BDS). As BDS are highly temperature-sensitive and valuable, this collaboration seeks to improve efficiency and safety in their transportation within the industry. The partnership built on years of collaboration, leveraging the established positions and expertise of both Sartorius and va-Q-tec in the field.

Jan-2023: Sartorius AG extended collaboration with RoosterBio Inc., a privately held cell manufacturing platform technology company, to tackle purification challenges and set up scalable downstream manufacturing for exosome-based therapies. The partnership aimed to deliver high-quality solutions for an hMSC-based exosome production platform, emphasizing top-tier yield, purity, and potency. The collaboration also focused on developing comprehensive analytical techniques for characterizing exosomes and the entire range of extracellular vesicles (EVs), establishing quantitative strategies for quality control in exosome purification intermediates and final drug products.

Product Launches and Product Expansions:

Sep-2022: Thermo Fisher Scientific, Inc. introduced the Thermo Scientific DynaSpin Single-Use Centrifuge system, designed for large-scale cell culture harvesting. Streamlining the process in single-use bioprocessing, it reduces the required depth filtration cartridges, maintaining or improving product yield compared to traditional systems. The DynaSpin solution enhances operational efficiency, cost-effectiveness, and sustainability in biologics production.

Acquisition and Mergers:

Jun-2023: Merck KGaA completed the acquisition of Prometheus Biosciences, Inc., making it a wholly owned subsidiary. Under the acquisition, Prometheus' common stock ceased trading on the Nasdaq Global Market, furthering Merck's presence in immunology, enhancing their pipeline, and strengthening their ability to provide patient value. This strategic and decisive move aligned with Merck's commitment to science and value.

Dec-2022: Merck KGaA acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as "Breez", to enhance its therapeutic protein upstream portfolio with the "Breez" 2 ml micro-bioreactor platform. This supports scalable cell-based perfusion bioreactor processes from 2 mL to 2000L, aiding rapid lab-scale development. The acquisition also opens possibilities for future development in novel applications, including cell therapies.

Apr-2022: Merck KGaA acquired the MAST (Modular Automated Sampling Technology) platform from Lonza to enhance its bioprocessing portfolio. Merck utilized the MAST platform, an automated, aseptic bioreactor sampling system developed in Bend, Oregon, USA. This technology, along with data analysis and management software, enabled Merck to provide distinctive and integrated solutions, assisting customers in optimizing their bioprocesses.

Geographical Expansions:

Jul-2023: Sartorius AG expanded its site in Yauco, Puerto Rico, by incorporating a new cell culture media manufacturing facility. Now officially opened, this 21,500-square-foot (2,000 square meters) facility aimed to enhance the company's cell culture media capacities, with a specific focus on serving customers in the Americas region. This addition solidified their extensive portfolio, particularly catering to customers in the Americas.

May-2023: Thermo Fisher Scientific, Inc. broadened its sterile manufacturing and research capabilities in the Asia-Pacific by inaugurating a new sterile drug facility in Singapore. Supported by the Singapore Economic Development Board, this good manufacturing practices facility complements Thermo Fisher's existing bioprocess design and customer experience centers, enhancing their operational labs with cutting-edge life science, analytical, and bioprocessing technologies.

Sep-2022: Eppendorf Group expanded its Julich bioprocess site by constructing a new multifunctional building. The added space increased DASGIP Information and Process Technology GmbH's production capacity by up to 20%, showcasing Eppendorf's long-term commitment to its Julich production location.

Apr-2022: Thermo Fisher Scientific set up a new single-use technology manufacturing site in Ogden, Utah, enhancing capacity for high-quality materials crucial in developing vaccines and therapies. This expansion strengthens the company's Utah presence and facilitates close collaboration with the Logan site, tapping into a skilled workforce for manufacturing intricate, customized solutions.

Nov-2021: Lonza Group AG expanded its manufacturing capacity to enhance microbial development capabilities in Switzerland, by expanding laboratory space and equipment to increase capacity for development services focusing on microbial-derived proteins. This extension supports new projects in Lonza's existing manufacturing assets and complements the previously announced mid-scale microbial capacity expansion. Strengthening upstream, downstream, and process analytics support, these expanded development services address the complexities of manufacturing processes in microbial expression systems.

Sep-2021: Sartorius AG expanded its Michigan presence by opening a 130,000-square-foot facility in Ann Arbor. The center of excellence consolidated operations in Washtenaw County for laboratory and Bioprocess products and services in North America. The focus is on delivering innovative solutions to aid customers in developing drugs to cure, prevent, and halt diseases.

May-2021: Lonza Group AG expanded its mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US). The expansion in Visp included a new large-scale facility with six 20,000L bioreactors to address the growing demand for biologics. Encompassing approximately 27,500 m2, the state-of-the-art facility, equipped with perfusion capabilities, was designed for high-titer processes and the next generation of mammalian biologics.

Sep-2020: Thermo Fisher Scientific Inc. opened the Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri, located near its expanded biologics manufacturing facility. The BCC, merging expertise from Thermo Fisher's bioproduction and pharma services, aimed to boost innovation and productivity for biopharma companies. This initiative responds to the increasing demand for flexible, scalable solutions in biologics development and manufacturing, improving workflows and expediting product launches for customers.

Scope of the Study

Market Segments covered in the Report:

By Scale

• Industrial Scale
• Small Scale

By Use Type

• Multi Use
• Single Use

By Mode

• In-house
• Outsourced

By Application

• Biopharmaceuticals
• Speciality Industrial Chemicals
• Environmental Aids

By Workflow

• Downstream Processing
• Fermentation
• Upstream Processing

By Product

• Bioreactors/Fermenters
• Cell Culture Products
• Filtration Assemblies
• Bioreactors Accessories
• Bags & Containers
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• GE healthcare
• Corning Incorporated
• Sartorius AG
• Lonza Group AG (Capsugel)
• Meissner Filtration Products, Inc.
• Boehringer Ingelheim International GmbH
• F. Hoffmann-La Roche Ltd.
• Eppendorf SE

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Large And Small-scale Bioprocessing Market, by Scale
  • 1.4.2 Global Large And Small-scale Bioprocessing Market, by Use Type
  • 1.4.3 Global Large And Small-scale Bioprocessing Market, by Mode
  • 1.4.4 Global Large And Small-scale Bioprocessing Market, by Application
  • 1.4.5 Global Large And Small-scale Bioprocessing Market, by Workflow
  • 1.4.6 Global Large And Small-scale Bioprocessing Market, by Product
  • 1.4.7 Global Large And Small-scale Bioprocessing Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market At a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
  • 4.2.4 Geographical Expansion
• 4.3 Top Winning Strategies
  • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.3.2 Key Strategic Move: (Geographical Expansions : 2019, Jan - 2023, Jul) Leading Players
• 4.4 Porter's Five Forces Analysis

Chapter 5. Global Large And Small-scale Bioprocessing Market by Scale

• 5.1 Global Industrial Scale Market by Region
• 5.2 Global Small Scale Market by Region

Chapter 6. Global Large And Small-scale Bioprocessing Market by Use Type

• 6.1 Global Multi Use Market by Region
• 6.2 Global Single Use Market by Region

Chapter 7. Global Large And Small-scale Bioprocessing Market by Mode

• 7.1 Global In-house Market by Region
• 7.2 Global Outsourced Market by Region

Chapter 8. Global Large And Small-scale Bioprocessing Market by Application

• 8.1 Global Biopharmaceuticals Market by Region
• 8.2 Global Speciality Industrial Chemicals Market by Region
• 8.3 Global Environmental Aids Market by Region

Chapter 9. Global Large And Small-scale Bioprocessing Market by Workflow

• 9.1 Global Downstream Processing Market by Region
• 9.2 Global Fermentation Market by Region
• 9.3 Global Upstream Processing Market by Region

Chapter 10. Global Large And Small-scale Bioprocessing Market by Product

• 10.1 Global Bioreactors/Fermenters Market by Region
• 10.2 Global Cell Culture Products Market by Region
• 10.3 Global Filtration Assemblies Market by Region
• 10.4 Global Bioreactors Accessories Market by Region
• 10.5 Global Bags & Containers Market by Region
• 10.6 Global Others Market by Region

Chapter 11. Global Large And Small-scale Bioprocessing Market by Region

• 11.1 North America Large And Small-scale Bioprocessing Market
  • 11.1.1 North America Large And Small-scale Bioprocessing Market by Scale
    • 11.1.1.1 North America Industrial Scale Market by Region
    • 11.1.1.2 North America Small Scale Market by Region
  • 11.1.2 North America Large And Small-scale Bioprocessing Market by Use Type
    • 11.1.2.1 North America Multi Use Market by Region
    • 11.1.2.2 North America Single Use Market by Region
  • 11.1.3 North America Large And Small-scale Bioprocessing Market by Mode
    • 11.1.3.1 North America In-house Market by Country
    • 11.1.3.2 North America Outsourced Market by Country
  • 11.1.4 North America Large And Small-scale Bioprocessing Market by Application
    • 11.1.4.1 North America Biopharmaceuticals Market by Country
    • 11.1.4.2 North America Speciality Industrial Chemicals Market by Country
    • 11.1.4.3 North America Environmental Aids Market by Country
  • 11.1.5 North America Large And Small-scale Bioprocessing Market by Workflow
    • 11.1.5.1 North America Downstream Processing Market by Country
    • 11.1.5.2 North America Fermentation Market by Country
    • 11.1.5.3 North America Upstream Processing Market by Country
  • 11.1.6 North America Large And Small-scale Bioprocessing Market by Product
    • 11.1.6.1 North America Bioreactors/Fermenters Market by Country
    • 11.1.6.2 North America Cell Culture Products Market by Country
    • 11.1.6.3 North America Filtration Assemblies Market by Country
    • 11.1.6.4 North America Bioreactors Accessories Market by Country
    • 11.1.6.5 North America Bags & Containers Market by Country
    • 11.1.6.6 North America Others Market by Country
  • 11.1.7 North America Large And Small-scale Bioprocessing Market by Country
    • 11.1.7.1 US Large And Small-scale Bioprocessing Market
      • 11.1.7.1.1 US Large And Small-scale Bioprocessing Market by Scale
      • 11.1.7.1.2 US Large And Small-scale Bioprocessing Market by Use Type
      • 11.1.7.1.3 US Large And Small-scale Bioprocessing Market by Mode
      • 11.1.7.1.4 US Large And Small-scale Bioprocessing Market by Application
      • 11.1.7.1.5 US Large And Small-scale Bioprocessing Market by Workflow
      • 11.1.7.1.6 US Large And Small-scale Bioprocessing Market by Product
    • 11.1.7.2 Canada Large And Small-scale Bioprocessing Market
      • 11.1.7.2.1 Canada Large And Small-scale Bioprocessing Market by Scale
      • 11.1.7.2.2 Canada Large And Small-scale Bioprocessing Market by Use Type
      • 11.1.7.2.3 Canada Large And Small-scale Bioprocessing Market by Mode
      • 11.1.7.2.4 Canada Large And Small-scale Bioprocessing Market by Application
      • 11.1.7.2.5 Canada Large And Small-scale Bioprocessing Market by Workflow
      • 11.1.7.2.6 Canada Large And Small-scale Bioprocessing Market by Product
    • 11.1.7.3 Mexico Large And Small-scale Bioprocessing Market
      • 11.1.7.3.1 Mexico Large And Small-scale Bioprocessing Market by Scale
      • 11.1.7.3.2 Mexico Large And Small-scale Bioprocessing Market by Use Type
      • 11.1.7.3.3 Mexico Large And Small-scale Bioprocessing Market by Mode
      • 11.1.7.3.4 Mexico Large And Small-scale Bioprocessing Market by Application
      • 11.1.7.3.5 Mexico Large And Small-scale Bioprocessing Market by Workflow
      • 11.1.7.3.6 Mexico Large And Small-scale Bioprocessing Market by Product
    • 11.1.7.4 Rest of North America Large And Small-scale Bioprocessing Market
      • 11.1.7.4.1 Rest of North America Large And Small-scale Bioprocessing Market by Scale
      • 11.1.7.4.2 Rest of North America Large And Small-scale Bioprocessing Market by Use Type
      • 11.1.7.4.3 Rest of North America Large And Small-scale Bioprocessing Market by Mode
      • 11.1.7.4.4 Rest of North America Large And Small-scale Bioprocessing Market by Application
      • 11.1.7.4.5 Rest of North America Large And Small-scale Bioprocessing Market by Workflow
      • 11.1.7.4.6 Rest of North America Large And Small-scale Bioprocessing Market by Product
• 11.2 Europe Large And Small-scale Bioprocessing Market
  • 11.2.1 Europe Large And Small-scale Bioprocessing Market by Scale
    • 11.2.1.1 Europe Industrial Scale Market by Country
    • 11.2.1.2 Europe Small Scale Market by Country
  • 11.2.2 Europe Large And Small-scale Bioprocessing Market by Use Type
    • 11.2.2.1 Europe Multi Use Market by Country
    • 11.2.2.2 Europe Single Use Market by Country
  • 11.2.3 Europe Large And Small-scale Bioprocessing Market by Mode
    • 11.2.3.1 Europe In-house Market by Country
    • 11.2.3.2 Europe Outsourced Market by Country
  • 11.2.4 Europe Large And Small-scale Bioprocessing Market by Application
    • 11.2.4.1 Europe Biopharmaceuticals Market by Country
    • 11.2.4.2 Europe Speciality Industrial Chemicals Market by Country
    • 11.2.4.3 Europe Environmental Aids Market by Country
  • 11.2.5 Europe Large And Small-scale Bioprocessing Market by Workflow
    • 11.2.5.1 Europe Downstream Processing Market by Country
    • 11.2.5.2 Europe Fermentation Market by Country
    • 11.2.5.3 Europe Upstream Processing Market by Country
  • 11.2.6 Europe Large And Small-scale Bioprocessing Market by Product
    • 11.2.6.1 Europe Bioreactors/Fermenters Market by Country
    • 11.2.6.2 Europe Cell Culture Products Market by Country
    • 11.2.6.3 Europe Filtration Assemblies Market by Country
    • 11.2.6.4 Europe Bioreactors Accessories Market by Country
    • 11.2.6.5 Europe Bags & Containers Market by Country
    • 11.2.6.6 Europe Others Market by Country
  • 11.2.7 Europe Large And Small-scale Bioprocessing Market by Country
    • 11.2.7.1 Germany Large And Small-scale Bioprocessing Market
      • 11.2.7.1.1 Germany Large And Small-scale Bioprocessing Market by Scale
      • 11.2.7.1.2 Germany Large And Small-scale Bioprocessing Market by Use Type
      • 11.2.7.1.3 Germany Large And Small-scale Bioprocessing Market by Mode
      • 11.2.7.1.4 Germany Large And Small-scale Bioprocessing Market by Application
      • 11.2.7.1.5 Germany Large And Small-scale Bioprocessing Market by Workflow
      • 11.2.7.1.6 Germany Large And Small-scale Bioprocessing Market by Product
    • 11.2.7.2 UK Large And Small-scale Bioprocessing Market
      • 11.2.7.2.1 UK Large And Small-scale Bioprocessing Market by Scale
      • 11.2.7.2.2 UK Large And Small-scale Bioprocessing Market by Use Type
      • 11.2.7.2.3 UK Large And Small-scale Bioprocessing Market by Mode
      • 11.2.7.2.4 UK Large And Small-scale Bioprocessing Market by Application
      • 11.2.7.2.5 UK Large And Small-scale Bioprocessing Market by Workflow
      • 11.2.7.2.6 UK Large And Small-scale Bioprocessing Market by Product
    • 11.2.7.3 France Large And Small-scale Bioprocessing Market
      • 11.2.7.3.1 France Large And Small-scale Bioprocessing Market by Scale
      • 11.2.7.3.2 France Large And Small-scale Bioprocessing Market by Use Type
      • 11.2.7.3.3 France Large And Small-scale Bioprocessing Market by Mode
      • 11.2.7.3.4 France Large And Small-scale Bioprocessing Market by Application
      • 11.2.7.3.5 France Large And Small-scale Bioprocessing Market by Workflow
      • 11.2.7.3.6 France Large And Small-scale Bioprocessing Market by Product
    • 11.2.7.4 Russia Large And Small-scale Bioprocessing Market
      • 11.2.7.4.1 Russia Large And Small-scale Bioprocessing Market by Scale
      • 11.2.7.4.2 Russia Large And Small-scale Bioprocessing Market by Use Type
      • 11.2.7.4.3 Russia Large And Small-scale Bioprocessing Market by Mode
      • 11.2.7.4.4 Russia Large And Small-scale Bioprocessing Market by Application
      • 11.2.7.4.5 Russia Large And Small-scale Bioprocessing Market by Workflow
      • 11.2.7.4.6 Russia Large And Small-scale Bioprocessing Market by Product
    • 11.2.7.5 Spain Large And Small-scale Bioprocessing Market
      • 11.2.7.5.1 Spain Large And Small-scale Bioprocessing Market by Scale
      • 11.2.7.5.2 Spain Large And Small-scale Bioprocessing Market by Use Type
      • 11.2.7.5.3 Spain Large And Small-scale Bioprocessing Market by Mode
      • 11.2.7.5.4 Spain Large And Small-scale Bioprocessing Market by Application
      • 11.2.7.5.5 Spain Large And Small-scale Bioprocessing Market by Workflow
      • 11.2.7.5.6 Spain Large And Small-scale Bioprocessing Market by Product
    • 11.2.7.6 Italy Large And Small-scale Bioprocessing Market
      • 11.2.7.6.1 Italy Large And Small-scale Bioprocessing Market by Scale
      • 11.2.7.6.2 Italy Large And Small-scale Bioprocessing Market by Use Type
      • 11.2.7.6.3 Italy Large And Small-scale Bioprocessing Market by Mode
      • 11.2.7.6.4 Italy Large And Small-scale Bioprocessing Market by Application
      • 11.2.7.6.5 Italy Large And Small-scale Bioprocessing Market by Workflow
      • 11.2.7.6.6 Italy Large And Small-scale Bioprocessing Market by Product
    • 11.2.7.7 Rest of Europe Large And Small-scale Bioprocessing Market
      • 11.2.7.7.1 Rest of Europe Large And Small-scale Bioprocessing Market by Scale
      • 11.2.7.7.2 Rest of Europe Large And Small-scale Bioprocessing Market by Use Type
      • 11.2.7.7.3 Rest of Europe Large And Small-scale Bioprocessing Market by Mode
      • 11.2.7.7.4 Rest of Europe Large And Small-scale Bioprocessing Market by Application
      • 11.2.7.7.5 Rest of Europe Large And Small-scale Bioprocessing Market by Workflow
      • 11.2.7.7.6 Rest of Europe Large And Small-scale Bioprocessing Market by Product
• 11.3 Asia Pacific Large And Small-scale Bioprocessing Market
  • 11.3.1 Asia Pacific Large And Small-scale Bioprocessing Market by Scale
    • 11.3.1.1 Asia Pacific Industrial Scale Market by Country
    • 11.3.1.2 Asia Pacific Small Scale Market by Country
  • 11.3.2 Asia Pacific Large And Small-scale Bioprocessing Market by Use Type
    • 11.3.2.1 Asia Pacific Multi Use Market by Country
    • 11.3.2.2 Asia Pacific Single Use Market by Country
  • 11.3.3 Asia Pacific Large And Small-scale Bioprocessing Market by Mode
    • 11.3.3.1 Asia Pacific In-house Market by Country
    • 11.3.3.2 Asia Pacific Outsourced Market by Country
  • 11.3.4 Asia Pacific Large And Small-scale Bioprocessing Market by Application
    • 11.3.4.1 Asia Pacific Biopharmaceuticals Market by Country
    • 11.3.4.2 Asia Pacific Speciality Industrial Chemicals Market by Country
    • 11.3.4.3 Asia Pacific Environmental Aids Market by Country
  • 11.3.5 Asia Pacific Large And Small-scale Bioprocessing Market by Workflow
    • 11.3.5.1 Asia Pacific Downstream Processing Market by Country
    • 11.3.5.2 Asia Pacific Fermentation Market by Country
    • 11.3.5.3 Asia Pacific Upstream Processing Market by Country
  • 11.3.6 Asia Pacific Large And Small-scale Bioprocessing Market by Product
    • 11.3.6.1 Asia Pacific Bioreactors/Fermenters Market by Country
    • 11.3.6.2 Asia Pacific Cell Culture Products Market by Country
    • 11.3.6.3 Asia Pacific Filtration Assemblies Market by Country
    • 11.3.6.4 Asia Pacific Bioreactors Accessories Market by Country
    • 11.3.6.5 Asia Pacific Bags & Containers Market by Country
    • 11.3.6.6 Asia Pacific Others Market by Country
  • 11.3.7 Asia Pacific Large And Small-scale Bioprocessing Market by Country
    • 11.3.7.1 China Large And Small-scale Bioprocessing Market
      • 11.3.7.1.1 China Large And Small-scale Bioprocessing Market by Scale
      • 11.3.7.1.2 China Large And Small-scale Bioprocessing Market by Use Type
      • 11.3.7.1.3 China Large And Small-scale Bioprocessing Market by Mode
      • 11.3.7.1.4 China Large And Small-scale Bioprocessing Market by Application
      • 11.3.7.1.5 China Large And Small-scale Bioprocessing Market by Workflow
      • 11.3.7.1.6 China Large And Small-scale Bioprocessing Market by Product
    • 11.3.7.2 Japan Large And Small-scale Bioprocessing Market
      • 11.3.7.2.1 Japan Large And Small-scale Bioprocessing Market by Scale
      • 11.3.7.2.2 Japan Large And Small-scale Bioprocessing Market by Use Type
      • 11.3.7.2.3 Japan Large And Small-scale Bioprocessing Market by Mode
      • 11.3.7.2.4 Japan Large And Small-scale Bioprocessing Market by Application
      • 11.3.7.2.5 Japan Large And Small-scale Bioprocessing Market by Workflow
      • 11.3.7.2.6 Japan Large And Small-scale Bioprocessing Market by Product
    • 11.3.7.3 India Large And Small-scale Bioprocessing Market
      • 11.3.7.3.1 India Large And Small-scale Bioprocessing Market by Scale
      • 11.3.7.3.2 India Large And Small-scale Bioprocessing Market by Use Type
      • 11.3.7.3.3 India Large And Small-scale Bioprocessing Market by Mode
      • 11.3.7.3.4 India Large And Small-scale Bioprocessing Market by Application
      • 11.3.7.3.5 India Large And Small-scale Bioprocessing Market by Workflow
      • 11.3.7.3.6 India Large And Small-scale Bioprocessing Market by Product
    • 11.3.7.4 South Korea Large And Small-scale Bioprocessing Market
      • 11.3.7.4.1 South Korea Large And Small-scale Bioprocessing Market by Scale
      • 11.3.7.4.2 South Korea Large And Small-scale Bioprocessing Market by Use Type
      • 11.3.7.4.3 South Korea Large And Small-scale Bioprocessing Market by Mode
      • 11.3.7.4.4 South Korea Large And Small-scale Bioprocessing Market by Application
      • 11.3.7.4.5 South Korea Large And Small-scale Bioprocessing Market by Workflow
      • 11.3.7.4.6 South Korea Large And Small-scale Bioprocessing Market by Product
    • 11.3.7.5 Singapore Large And Small-scale Bioprocessing Market
      • 11.3.7.5.1 Singapore Large And Small-scale Bioprocessing Market by Scale
      • 11.3.7.5.2 Singapore Large And Small-scale Bioprocessing Market by Use Type
      • 11.3.7.5.3 Singapore Large And Small-scale Bioprocessing Market by Mode
      • 11.3.7.5.4 Singapore Large And Small-scale Bioprocessing Market by Application
      • 11.3.7.5.5 Singapore Large And Small-scale Bioprocessing Market by Workflow
      • 11.3.7.5.6 Singapore Large And Small-scale Bioprocessing Market by Product
    • 11.3.7.6 Malaysia Large And Small-scale Bioprocessing Market
      • 11.3.7.6.1 Malaysia Large And Small-scale Bioprocessing Market by Scale
      • 11.3.7.6.2 Malaysia Large And Small-scale Bioprocessing Market by Use Type
      • 11.3.7.6.3 Malaysia Large And Small-scale Bioprocessing Market by Mode
      • 11.3.7.6.4 Malaysia Large And Small-scale Bioprocessing Market by Application
      • 11.3.7.6.5 Malaysia Large And Small-scale Bioprocessing Market by Workflow
      • 11.3.7.6.6 Malaysia Large And Small-scale Bioprocessing Market by Product
    • 11.3.7.7 Rest of Asia Pacific Large And Small-scale Bioprocessing Market
      • 11.3.7.7.1 Rest of Asia Pacific Large And Small-scale Bioprocessing Market by Scale
      • 11.3.7.7.2 Rest of Asia Pacific Large And Small-scale Bioprocessing Market by Use Type
      • 11.3.7.7.3 Rest of Asia Pacific Large And Small-scale Bioprocessing Market by Mode
      • 11.3.7.7.4 Rest of Asia Pacific Large And Small-scale Bioprocessing Market by Application
      • 11.3.7.7.5 Rest of Asia Pacific Large And Small-scale Bioprocessing Market by Workflow
      • 11.3.7.7.6 Rest of Asia Pacific Large And Small-scale Bioprocessing Market by Product
• 11.4 LAMEA Large And Small-scale Bioprocessing Market
  • 11.4.1 LAMEA Large And Small-scale Bioprocessing Market by Scale
    • 11.4.1.1 LAMEA Industrial Scale Market by Country
    • 11.4.1.2 LAMEA Small Scale Market by Country
  • 11.4.2 LAMEA Large And Small-scale Bioprocessing Market by Use Type
    • 11.4.2.1 LAMEA Multi Use Market by Country
    • 11.4.2.2 LAMEA Single Use Market by Country
  • 11.4.3 LAMEA Large And Small-scale Bioprocessing Market by Mode
    • 11.4.3.1 LAMEA In-house Market by Country
    • 11.4.3.2 LAMEA Outsourced Market by Country
  • 11.4.4 LAMEA Large And Small-scale Bioprocessing Market by Application
    • 11.4.4.1 LAMEA Biopharmaceuticals Market by Country
    • 11.4.4.2 LAMEA Speciality Industrial Chemicals Market by Country
    • 11.4.4.3 LAMEA Environmental Aids Market by Country
  • 11.4.5 LAMEA Large And Small-scale Bioprocessing Market by Workflow
    • 11.4.5.1 LAMEA Downstream Processing Market by Country
    • 11.4.5.2 LAMEA Fermentation Market by Country
    • 11.4.5.3 LAMEA Upstream Processing Market by Country
  • 11.4.6 LAMEA Large And Small-scale Bioprocessing Market by Product
    • 11.4.6.1 LAMEA Bioreactors/Fermenters Market by Country
    • 11.4.6.2 LAMEA Cell Culture Products Market by Country
    • 11.4.6.3 LAMEA Filtration Assemblies Market by Country
    • 11.4.6.4 LAMEA Bioreactors Accessories Market by Country
    • 11.4.6.5 LAMEA Bags & Containers Market by Country
    • 11.4.6.6 LAMEA Others Market by Country
  • 11.4.7 LAMEA Large And Small-scale Bioprocessing Market by Country
    • 11.4.7.1 Brazil Large And Small-scale Bioprocessing Market
      • 11.4.7.1.1 Brazil Large And Small-scale Bioprocessing Market by Scale
      • 11.4.7.1.2 Brazil Large And Small-scale Bioprocessing Market by Use Type
      • 11.4.7.1.3 Brazil Large And Small-scale Bioprocessing Market by Mode
      • 11.4.7.1.4 Brazil Large And Small-scale Bioprocessing Market by Application
      • 11.4.7.1.5 Brazil Large And Small-scale Bioprocessing Market by Workflow
      • 11.4.7.1.6 Brazil Large And Small-scale Bioprocessing Market by Product
    • 11.4.7.2 Argentina Large And Small-scale Bioprocessing Market
      • 11.4.7.2.1 Argentina Large And Small-scale Bioprocessing Market by Scale
      • 11.4.7.2.2 Argentina Large And Small-scale Bioprocessing Market by Use Type
      • 11.4.7.2.3 Argentina Large And Small-scale Bioprocessing Market by Mode
      • 11.4.7.2.4 Argentina Large And Small-scale Bioprocessing Market by Application
      • 11.4.7.2.5 Argentina Large And Small-scale Bioprocessing Market by Workflow
      • 11.4.7.2.6 Argentina Large And Small-scale Bioprocessing Market by Product
    • 11.4.7.3 UAE Large And Small-scale Bioprocessing Market
      • 11.4.7.3.1 UAE Large And Small-scale Bioprocessing Market by Scale
      • 11.4.7.3.2 UAE Large And Small-scale Bioprocessing Market by Use Type
      • 11.4.7.3.3 UAE Large And Small-scale Bioprocessing Market by Mode
      • 11.4.7.3.4 UAE Large And Small-scale Bioprocessing Market by Application
      • 11.4.7.3.5 UAE Large And Small-scale Bioprocessing Market by Workflow
      • 11.4.7.3.6 UAE Large And Small-scale Bioprocessing Market by Product
    • 11.4.7.4 Saudi Arabia Large And Small-scale Bioprocessing Market
      • 11.4.7.4.1 Saudi Arabia Large And Small-scale Bioprocessing Market by Scale
      • 11.4.7.4.2 Saudi Arabia Large And Small-scale Bioprocessing Market by Use Type
      • 11.4.7.4.3 Saudi Arabia Large And Small-scale Bioprocessing Market by Mode
      • 11.4.7.4.4 Saudi Arabia Large And Small-scale Bioprocessing Market by Application
      • 11.4.7.4.5 Saudi Arabia Large And Small-scale Bioprocessing Market by Workflow
      • 11.4.7.4.6 Saudi Arabia Large And Small-scale Bioprocessing Market by Product
    • 11.4.7.5 South Africa Large And Small-scale Bioprocessing Market
      • 11.4.7.5.1 South Africa Large And Small-scale Bioprocessing Market by Scale
      • 11.4.7.5.2 South Africa Large And Small-scale Bioprocessing Market by Use Type
      • 11.4.7.5.3 South Africa Large And Small-scale Bioprocessing Market by Mode
      • 11.4.7.5.4 South Africa Large And Small-scale Bioprocessing Market by Application
      • 11.4.7.5.5 South Africa Large And Small-scale Bioprocessing Market by Workflow
      • 11.4.7.5.6 South Africa Large And Small-scale Bioprocessing Market by Product
    • 11.4.7.6 Nigeria Large And Small-scale Bioprocessing Market
      • 11.4.7.6.1 Nigeria Large And Small-scale Bioprocessing Market by Scale
      • 11.4.7.6.2 Nigeria Large And Small-scale Bioprocessing Market by Use Type
      • 11.4.7.6.3 Nigeria Large And Small-scale Bioprocessing Market by Mode
      • 11.4.7.6.4 Nigeria Large And Small-scale Bioprocessing Market by Application
      • 11.4.7.6.5 Nigeria Large And Small-scale Bioprocessing Market by Workflow
      • 11.4.7.6.6 Nigeria Large And Small-scale Bioprocessing Market by Product
    • 11.4.7.7 Rest of LAMEA Large And Small-scale Bioprocessing Market
      • 11.4.7.7.1 Rest of LAMEA Large And Small-scale Bioprocessing Market by Scale
      • 11.4.7.7.2 Rest of LAMEA Large And Small-scale Bioprocessing Market by Use Type
      • 11.4.7.7.3 Rest of LAMEA Large And Small-scale Bioprocessing Market by Mode
      • 11.4.7.7.4 Rest of LAMEA Large And Small-scale Bioprocessing Market by Application
      • 11.4.7.7.5 Rest of LAMEA Large And Small-scale Bioprocessing Market by Workflow
      • 11.4.7.7.6 Rest of LAMEA Large And Small-scale Bioprocessing Market by Product

Chapter 12. Company Profiles

• 12.1 Merck KGaA
  • 12.1.1 Company Overview
  • 12.1.2 Financial Analysis
  • 12.1.3 Segmental and Regional Analysis
  • 12.1.4 Research & Development Expense
  • 12.1.5 Recent strategies and developments:
    • 12.1.5.1 Partnerships, Collaborations, and Agreements:
    • 12.1.5.2 Acquisition and Mergers:
  • 12.1.6 SWOT Analysis
• 12.2 Thermo Fisher Scientific, Inc.
  • 12.2.1 Company Overview
  • 12.2.2 Financial Analysis
  • 12.2.3 Segmental and Regional Analysis
  • 12.2.4 Research & Development Expenses
  • 12.2.5 Recent strategies and developments:
    • 12.2.5.1 Product Launches and Product Expansions:
    • 12.2.5.2 Acquisition and Mergers:
    • 12.2.5.3 Geographical Expansions:
  • 12.2.6 SWOT Analysis
• 12.3 GE HealthCare Technologies, Inc.
  • 12.3.1 Company Overview
  • 12.3.2 Financial Analysis
  • 12.3.3 Segmental and Regional Analysis
  • 12.3.4 Research & Development Expenses
  • 12.3.5 SWOT Analysis
• 12.4 Corning Incorporated
  • 12.4.1 Company Overview
  • 12.4.2 Financial Analysis
  • 12.4.3 Segmental and Regional Analysis
  • 12.4.4 Research & Development Expenses
  • 12.4.5 SWOT Analysis
• 12.5 Sartorius AG
  • 12.5.1 Company Overview
  • 12.5.2 Financial Analysis
  • 12.5.3 Segmental and Regional Analysis
  • 12.5.4 Research & Development Expenses
  • 12.5.5 Recent strategies and developments:
    • 12.5.5.1 Partnerships, Collaborations, and Agreements:
    • 12.5.5.2 Product Launches and Product Expansions:
    • 12.5.5.3 Geographical Expansions:
  • 12.5.6 SWOT Analysis
• 12.6 Lonza Group Ltd. (Capsugel)
  • 12.6.1 Company Overview
  • 12.6.2 Financial Analysis
  • 12.6.3 Segmental and Regional Analysis
  • 12.6.4 Research & Development Expenses
  • 12.6.5 Recent strategies and developments:
    • 12.6.5.1 Geographical Expansions:
  • 12.6.6 SWOT Analysis
• 12.7 Meissner Filtration Products, Inc.
  • 12.7.1 Company Overview
  • 12.7.2 SWOT Analysis
• 12.8 Boehringer Ingelheim International Gmbh
  • 12.8.1 Company Overview
  • 12.8.2 Financial Analysis
  • 12.8.3 Regional & Segmental Analysis
  • 12.8.4 Research & Development Expenses
  • 12.8.5 Recent strategies and developments:
    • 12.8.5.1 Partnerships, Collaborations, and Agreements:
    • 12.8.5.2 Geographical Expansions:
  • 12.8.6 SWOT Analysis
• 12.9 F. Hoffmann-La Roche Ltd.
  • 12.9.1 Company Overview
  • 12.9.2 Financial Analysis
  • 12.9.3 Segmental and Regional Analysis
  • 12.9.4 Research & Development Expense
  • 12.9.5 Recent strategies and developments:
    • 12.9.5.1 Partnerships, Collaborations, and Agreements:
  • 12.9.6 SWOT Analysis
• 12.10. Eppendorf SE
  • 12.10.1 Company Overview
  • 12.10.2 Financial Analysis
  • 12.10.3 Segmental and Regional Analysis
  • 12.10.4 Research & Development Expenses
  • 12.10.5 Recent strategies and developments:
    • 12.10.5.1 Geographical Expansions:
  • 12.10.6 SWOT Analysis

Chapter 13. Winning Imperatives of Large And Small-scale Bioprocessing Market: